#Ozempicface has become a common complaint for those who experience a large amount of weight loss after using the popular medication. Ozempic is part of a new class of drugs called GLP-1 agonists. Andrea Bedrosian, MD, director of bariatrics at North Shore University Hospital and Long Island Jewish Medical Center, breaks down what anyone taking #weightlossmedication which also include #Wegovy, #Mounjaro and #Zepbound, should know about potential side effects.
Learn more:
Follow Northwell on Social Media:
Ozempic Face: What You Need To Know For Country: United States. City: Charleston, Cleveland, Salt Lake City, Sioux Falls, Wichita
